The Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration's Patient‐Reported Outcomes (PRO) working group has systematically reviewed and published consensus guidelines for QoL endpoints in NF1, NF2, and schwannomatosis trials. The gene discussed is NF1; the disease is neurofibromatosis.